Latham & Watkins advised Vencer Energy LLC on the deal; Kirkland & Elis acted for Civitas Resources. Civitas Resources, Inc. (NYSE: CIVI) has entered into an...
Civitas’ US$2.15 Billion Assets Acquisition From Vencer Energy LLC
Xerox’s US$542 Million Repurchase of Shares From Carl C. Icahn and Affiliates
White & Case LLP advised Xerox , Willkie Farr & Gallagher represented the Special Committee of the Board of Directors of Xerox Holdings Corporation, and Latham...
Kimco Realty Corporation’s US$500 Million Equity Program
Latham & Watkins represented Kimco Realty while Sidley advised the agents. Kimco Realty Corporation (NYSE: KIM) has priced a public offering of $500 million aggregate principal amount...
Integrity Marketing’s US$6.2 Billion Refinancing From Blue Owl
Latham & Watkins LLP represented direct lender Blue Owl Capital Corporation. Integrity Marketing, an investment of Harvest Partners and a leading distributor of life and health...
Cinven’s Acquisition of SYNLAB AG
On the transaction, Clifford Chance has acted for Ephios Luxembourg; Kirkland & Ellis has advised Cinven; Latham & Watkins has advised Novo Holdings A/S The Fifth...
Structure Therapeutics’ US$300 Million Private Placement Equity Financing
Latham & Watkins LLP represents Jefferies LLC and Leerink Partners LLC acting as placement agents in the financing. Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global...
Pencil Biosciences’ £5.6 Million Seed Financing
Latham & Watkins has advised Octopus Ventures and Northern Gritstone. Pencil Biosciences closed its £5.6 million Series Seed funding round. The round was led by Octopus...
Dynasty Equity’s Strategic Minority Investment in Liverpool F.C.
Latham & Watkins LLC and Kirkland & Ellis advised Dynasty Equity on the transaction. Fenway Sports Group has sold a minority stake in Liverpool to US private...
Immunovant’s US$450 Million Common Stock Financing
Latham & Watkins represent the underwriters Leerink Partners LLC; Piper Sandler & Co.; Guggenheim Securities, LLC; Wells Fargo Securities, LLC; LifeSci Capital LLC. Immunovant, Inc. (Nasdaq:...
Platinum Equity’s Acquisition of The Cook & Boardman Group
Latham & Watkins and Willkie Farr & Gallagher LLP advised Platinum Equity; Gibson, Dunn & Crutcher LLP served as legal advisor to Cook & Boardman. Platinum...
Vistagen’s US$100 Million Underwritten Offering
Latham & Watkins LLP represents Vistagen in the offering. Vistagen Therapeutics, Inc. (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for...
IFM Investors’ Voluntary Tender Offer for Shares of Aleatica S.A.B. de C.V.
Gonzalez Calvillo, Latham & Watkins, Creel, García-Cuéllar, Aiza y Enriquez and Mijares, Angoitia, Cortés, y Fuentes, S.C. acted as legal advisor ont he deal. IFM Investors...